Quality of life in early prostate cancer: Do we know enough to treat?

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 691-701

  Talcott, J A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; HUMAN; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SEXUAL INTERCOURSE; TREATMENT PLANNING;

EID: 0029898527     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70361-0     Document Type: Article

References (32)

1. N.K. Aaronson Quality of life research in cancer clinical trials: A need for common rules and language Oncology (Williston Park) 4 1990 59
2. N.K. Aaronson S. Ahmedzai B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365
3. M.J. Barry F.J. Fowler Jr M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549
4. C.L. Bennett S. Greenfield H. Aronow Patterns of care related to age of men with prostate cancer Cancer 67 1991 2633
5. W.J. Catalona J.W. Basler Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy J Urol 150 1993 905
6. D.F. Cella D.S. Tulsky Measuring quality of life today: Methodological aspects Oncology (Williston Park) 4 1990 29
7. D.F. Cella D.S. Tulsky G. Gray The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure J Clin Oncol 11 1993 570
8. G.W. Chodak R.A. Thisted G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242
9. J. Clark P. Rieker L. Kalish Evaluation of the SF-36 measures of health related quality of life (HRQoL) in prostate cancer [abstract] Proc Annu Meet Am Soc Clin Oncol 12 1993 A1508
10. C. Fleming J.H. Wasson P.C. Albertsen A decision analysis of alternative treatment strategies for clinically localized prostate cancer JAMA 269 1993 2650
11. F. Fowler Jr M.J. Barry G. Lu-Yao Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993) Urology 42 1993 622
12. F.J.J. Fowler J.E. Wennberg R.P. Timothy Symptom status and quality of life following prostatectomy JAMA 259 1988 3018
13. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289
14. S. Greenfield H.U. Aronow R.M. Elashoff D. Watanabe Flaws in mortality data. The hazards of ignoring comorbid disease JAMA 260 1988 2253
15. S.J. Jacobsen S.K. Katusic E.J. Bergstralh Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing JAMA 274 1995 1445
16. J.E. Johansson H.O. Adami S.O. Andersson Natural history of localised prostatic cancer. A population-based study in 223 untreated patients Lancet 1 1989 799
17. M.D. Krahn J.E. Mahoney M.H. Eckman Screening for prostate cancer. A decision analytic view JAMA 272 1994 773
18. M. Litwin Health-related quality of life after treatment for localized prostate cancer Cancer 75 1995 2000
19. M.S. Litwin R.D. Hays A. Fink Quality-of-life outcomes in men treated for early prostate cancer JAMA 273 1995 129
20. C.A. McHorney J.E.J. Ware W. Rogers The validity and relative precision of MOS short-and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study Med Care 30 suppl 5 1992 MS253
21. D.M. McNair M. Lorr L.F. Droppleman Profile of Mood States ed 2 1981 Educational and Industrial Testing Service San Diego
22. C.M. Moinpour K.A. Hayden I.M. Thompson Quality of life assessment in Southwest Oncology Group trials Oncology (Williston Park) 4 1990 79
23. M.J. Moore B. O'Sullivan I.F. Tannock How expert physicians would wish to be treated if they had genitourinary cancer J Clin Oncol 6 1988 1736
24. M.P. O'Leary F.J. Fowler W.R. Lenderking A brief male sexual function inventory for urology Urology 46 1995 697
25. D.F. Paulson G.H. Lin W. Hinshaw S. Stephani Radical surgery versus radiotherapy for adenocarcinoma of the prostate J Urol 128 1982 502
26. A.L. Potosky B.A. Miller P.C. Albertsen B.S. Kramer The role of increasing detection in the rising incidence of prostate cancer JAMA 273 1995 548
27. C.A. Schag P.A. Ganz R.L. Heinrich Cancer Rehabilitation Evaluation System-short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument Cancer 68 1991 1406
28. M.S. Steiner R.A. Morton P.C. Walsh Impact of anatomical radical prostatectomy on urinary continence J Urol 145 1991 512
29. J.A. Talcott P. Rieker K. Propert Complications of treatment for early prostate cancer: A prospective, multi-institutional outcomes study [abstract] Proc Annu Meet Am Soc Clin Oncol 13 1994 A711
30. P.C. Walsh J.I. Epstein F.C. Lowe Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle J Urol 138 1987 823
31. J.H. Wasson C.C. Cushman R.C. Bruskewitz A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team Arch Fam Med 2 1993 487
32. T.J. Wilt M.K. Brawer The Prostate Cancer Intervention Versus Observation Trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer J Urol 152 1994 1910